Mike Hutton is the Vice President of Neurodegeneration Research at Eli Lilly and Company, a position they have held since 2018. Previously, they served as the Chief Scientific Officer for Neurodegenerative Diseases at Eli Lilly from 2009 to 2018. Their experience includes a role as a Consultant and Professor of Neuroscience at the Mayo Clinic from 1996 to 2007 and as Senior Director at Merck from 2007 to 2009. Mike earned a Bachelor's Degree in Biochemistry from The University of Manchester and a Ph.D. in Neuroscience from the Laboratory of Molecular Biology at the University of Cambridge.
This person is not in any teams
This person is not in any offices